MS/MS Services

Expert GLP & Non-GLP LC-MS/MS and GC-MS/MS bioanalytical and biomarker quantitation services in small and large molecules- from small volatiles, antibody drug conjugates, to protein therapeutics in any biological matrix. We provide on-time delivery of quantitative bioanalytical method development, transfer, and validation, and sample analysis to support drug candidates from discovery through phase IV clinical trials.

Learn more

MS/MS Research

Our reputation as a research-intensive organization keeps us at the front of new MS/MS bioanalytical techniques. In collaboration with technology leaders, Alturas has a successful history of transferring novel ideas to productive solution for the pharmaceutical industry. Alturas reserves resources for challenging assays and rush requests.

Learn more

Resources

A known pioneer in MicroFlow Liquid Chromatography (MFLC) and its applications to small and large molecule bioanalysis, and an active contributor in applying new microsampling techniques to routine sample analysis, recent and past publications, video, newsletters, and poster presentations produced by Alturas Analytics can be found here. We have an impressive history of leading the bioanalytical services industry with contributions from our research.

Learn more

Our Blog News & Events

  • ISSX 2019 - Alturas Presentations - Meet With Scientific Experts

    Oregon Convention Center
    28-31 July 2019
    Visit Alturas Analytics
    Booth #120

     

    ISSX meetings bring together a network of academic and industry research scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics.

     

    Visit Alturas Analytics at booth #120, or email ahoffman@alturasanalytics.com to discuss innovative solutions to bioanalytical challenges we face in our current landscape.
    Poster Presentations

    Development of LC-MS/MS Methods for the Quantitation of Commonly Co-administered Drugs and an Assessment of the Impact of their Presence on the Analysis and Stability of Novel Drug Candidates in Support of a Clinical Study
    P62
    Presented by Ryan Schmich

    Monday, June 29, 2019
    11:00 AM - 1:00 PM

    Quantitative Analysis of a Thyroid Hormone Biomarker Extracted from Whole Blood Using a Mitra® Microsampling Device
    P2
    Presented by Jason Watts, Ph.D.

    Monday, June 29, 2019
    11:00 AM - 1:00 PM
    Welcome Dr. Lori Payne

    Effective July 16, 2019, Alturas Analytics is thrilled to announce the appointment of Dr. Lori Payne to the Business Development team as Executive Director of Business Development joining Ann Hoffman, VP Strategic Development. Read More
    Upcoming Events

    July 28-31, 2019
    Poster Presentations
    Oregon Convention Center
    Portland, OR

    September 9-11, 2019
    Speaker: Jennifer Zimmer, Ph.D.
    Revere Hotel Boston Common
    Boston, MA

    October 3, 2019
    Exhibitor
    Foster City Crowne Plaza
    San Francisco, CA

    November 3-6, 2019
    Exhibitor
    Henry B. Gonzalez Convention Center
    San Antonio, TX


  • Welcome Dr. Lori Payne, Executive Director of Business Development

    Effective July 16, 2019, Alturas Analytics is thrilled to announce the appointment of Dr. Lori Payne to the Business Development team as Executive Director of Business Development joining Ann Hoffman, VP Strategic Development.

    "Dr. Payne brings a wealth of business development and laboratory operational experience to Alturas. She is well known in the field of bioanalytical and pharmacokinetic analysis for both large and small molecules as well as immunogenicity," says Ann Hoffman. Dr. Payne's focus will be developing new business opportunities in the bioanalysis of large and small molecules using LC-MS and innovative technologies.

    Dr. Payne has had a distinguished career in large pharma as well as managing and directing growth and development in Contract Research Organizations. She advanced steadily in her career at Merck from Senior Research Chemist to Group Leader and Senior Scientist. As Senior Scientist, she led a group of 8 PhD/MS/BS level PKDM department scientists in all aspects of project management, drug development, and bioanalytical analysis of pharmaceutical drugs using LC-MS and other analytical techniques. She subsequently joined the team at BASi (formerly LC Resources) to lead their West Coast Operations as Laboratory Director and General Manager. The site achieved numerous awards for their lean and continuous improvement focus. Dr. Payne was named “Manufacturing Leader of the Year” by the McMinnville  Economic Development Partnership. When the site was consolidated with two others, she was selected as Vice President to run the Analytical, Bioanalytical and Discovery Departments; a team of about 65 staff including quality assurance, sample management, and business development functions. Dr. Payne furthered her Business Development skills and strategies as the Director of the US Pharma BD Teams at Intertek.

    Dr. Payne earned a PhD in Chemistry from LSU Baton Rouge and a BS in Biochemistry at UC Davis.

    She says, “I’m honored to join the Alturas team which has an excellent reputation for quality work and superior science. I’m excited to merge my business skills with such a well-run continuous improvement minded laboratory with a heart.”

    Meet Dr. Lori Payne at the 12th International ISSX meeting, July 28-31. To schedule a time, email lpayne@alturasanalytics.com.

Take a Tour

We are Hiring!

Sample Custodian


Careers
NEW